Hims & Hers Health, Inc. filed its Form 10-Q for the quarterly period ended June 30, 2026, with the U.S. Securities and Exchange Commission on August 10, 2026, disclosing condensed consolidated balance sheet data and related financial information.

Key Highlights

  • Total assets of $3.628 billion: The company reported total assets of $3,628,814 thousand as of June 30, 2026, compared to $2,154,705 thousand as of December 31, 2025.
  • Cash and cash equivalents increased: Cash and cash equivalents were $609,811 thousand at June 30, 2026, up from $228,616 thousand at December 31, 2025.
  • Goodwill nearly quadrupled: Goodwill rose to $1,101,720 thousand at June 30, 2026, from $278,325 thousand at December 31, 2025.
  • Deferred acquisition payable surged: A deferred acquisition payable of $537,381 thousand appeared in current liabilities as of June 30, 2026, versus $1,479 thousand at December 31, 2025.
  • Receivables rose sharply: Receivables, net, increased to $375,291 thousand from $32,149 thousand at December 31, 2025.
  • Shares outstanding: As of August 7, 2026, 224,935,790 shares of Class A common stock and 8,377,623 shares of Class V common stock were issued and outstanding.

Hims & Hers Balance Sheet Shifts Significantly in First Half of 2026

According to the filing, Hims & Hers Health, Inc. (NYSE: HIMS) reported total assets of $3,628,814 thousand as of June 30, 2026, a substantial increase from $2,154,705 thousand at December 31, 2025. The company's current assets climbed to $1,384,613 thousand from $767,638 thousand over the same period, driven in part by the increase in cash and cash equivalents and a large rise in net receivables from $32,149 thousand to $375,291 thousand.

The filing shows goodwill increased to $1,101,720 thousand at June 30, 2026, compared to $278,325 thousand at December 31, 2025. Intangible assets, net, also rose to $422,809 thousand from $196,116 thousand. These changes, along with the deferred acquisition payable of $537,381 thousand appearing in current liabilities, suggest acquisition activity during the period, though the filing excerpt provided does not detail the specific transactions involved. Total current liabilities grew to $1,483,232 thousand from $404,431 thousand.

The company reported short-term available-for-sale investments of $231,237 thousand as of June 30, 2026, compared to $348,876 thousand at December 31, 2025, while long-term available-for-sale investments of $351,263 thousand reported at year-end 2025 were zero at the June 30, 2026 balance sheet date. The filing identifies the registrant as a large accelerated filer and notes that forward-looking statements are subject to risks and uncertainties described in the filing's risk factors section.

What Was Disclosed

The filing presents condensed consolidated balance sheet data for Hims & Hers Health, Inc. as of June 30, 2026, and December 31, 2025, showing significant increases in total assets, goodwill, intangible assets, receivables, and a new deferred acquisition payable, alongside share count information as of August 7, 2026.